Caldera Medical Acquires UVision 360 and the LUMINELLE Product Family

LumiThera Acquires Diopsys

November 11, 2021

Medical Devices

LumiThera, a commercial-stage ophthalmic medical device company, entered a definitive merger agreement to acquire Diopsys in a stock-for-stock transaction under which Diopsys will become a wholly owned subsidiary of LumiThera. The deal combines Diopsys' visual electrophysiology diagnostic systems with LumiThera's photobiomodulation treatment platform to create a coordinated light-based theranostic approach for diagnosing, treating and monitoring ocular disease.

Hahn & Company Acquires Cynosure and Merges It with Lutronic to Form Cynosure Lutronic

January 19, 2024

Medical Devices

Hahn & Company completed the acquisition of Cynosure and has combined it with Lutronic (which Hahn had recently acquired) under the newly formed parent Cynosure Lutronic, Inc. The merger creates a global leader in energy‑based medical aesthetic systems with an expanded product portfolio, R&D capabilities and a broader international commercial footprint.

Boston Scientific Acquires Lumenis Surgical Business from Baring Private Equity Asia for $1.07B

March 3, 2021

Medical Devices

Boston Scientific has agreed to acquire the Lumenis Surgical Business from Baring Private Equity Asia/Lumenis for USD 1.07 billion, subject to closing adjustments. The deal transfers Lumenis' surgical laser portfolio and global surgical team (including its Israeli laser center of excellence) to Boston Scientific to bolster its Urology strategy, while Lumenis — still owned by BPEA — will focus on Aesthetics and Vision.

Health Catalyst Acquires Lumeon Limited

August 8, 2024

Healthcare Services

Health Catalyst, Inc. (Nasdaq: HCAT) has completed its acquisition of Lumeon Limited, a digital health company that provides care orchestration software used by provider organizations in the U.S. and United Kingdom. The deal combines Lumeon's Care Orchestration platform with Health Catalyst's analytics and AI capabilities to expand clinical automation, improve care coordination, and support international growth, particularly in the U.K.

Bausch + Lomb Acquires Elios Vision

December 11, 2024

Medical Devices

Bausch + Lomb Corporation (through an affiliate) has acquired Elios Vision, Inc., developer of the ELIOS excimer-laser MIGS system, expanding Bausch + Lomb's glaucoma surgical capabilities and complementing its cataract surgery portfolio. The ELIOS technology, currently CE marked and marketed in the EU, is undergoing pursuit of FDA approval and will be commercialized more broadly through Bausch + Lomb's global cataract surgery channels.

Laborie Medical Technologies Acquires Pelvalon

October 13, 2021

Medical Devices

Laborie Medical Technologies Corp., a specialist medical technology company headquartered in Portsmouth, New Hampshire, has acquired Pelvalon, Inc., a Redwood City, California-based medical device company. Pelvalon’s Eclipse System is an FDA-cleared, non-surgical, patient-controlled device for women with fecal incontinence; the acquisition expands Laborie’s portfolio in pelvic floor and women’s health therapies.